This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Seikagaku Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Akira Koushinbou: Innovator in Aqueous Composition Technology
Introduction
Akira Koushinbou is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical compositions, particularly through his innovative work involving chondroitin sulfate and hyaluronic acid.
Latest Patents
Koushinbou holds a patent for a "Stabilized aqueous composition comprising chondroitin sulfate and hyaluronic acid." This invention relates to an aqueous composition that includes chondroitin sulfate, hyaluronic acid, and a pharmaceutically acceptable carrier, which can be stored at room temperature. Additionally, the patent encompasses a formulation that includes sorbitol along with the aforementioned components.
Career Highlights
Koushinbou is associated with Seikagaku Corporation, a company known for its advancements in biotechnology and pharmaceuticals. His work has contributed to the development of stable pharmaceutical formulations that enhance the efficacy of treatments involving chondroitin sulfate and hyaluronic acid.
Collaborations
Koushinbou has collaborated with notable colleagues, including Eiji Nogami and Noriko Oshima, who have also contributed to advancements in the field of pharmaceutical sciences.
Conclusion
Akira Koushinbou's innovative work in aqueous compositions has the potential to impact the pharmaceutical industry significantly. His contributions reflect a commitment to improving the stability and effectiveness of important medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile